✦ LIBER ✦

Pharmacology and clinical pharmacology of organic nitrates

✍ Scribed by H. Grobecker

Publisher: Springer
Year: 1990
Tongue: English
Weight: 469 KB
Volume: 38
Category: Article
ISSN: 0031-6970
DOI: 10.1007/bf01417558

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical toxicologic and pharmacologic s

Clinical toxicologic and pharmacologic studies of gallium nitrate

✍ Irwin H. Krakoff; Robert A. Newman; Ronald S. Goldberg 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 426 KB 👁 1 views

Clinical pharmacology of methotrexate

✍ Bertino, J. R. 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 746 KB

## Abstract Methotrexate (MTX), a potent folate antagonist by virtue of its ability to inhibit the enzyme dihydrofolate reductase [1], continues to be a useful cancer chemotherapeutic agent [2]. Information not only on its mechanism of action, but also its pharmacology has led to improved dosage sc

Clinical pharmacology of carvedilol

✍ Tomlinson, B. ;Prichard, B.N.C. ;Graham, B.R. ;Walden, R.J. 📂 Article 📅 1992 🏛 Springer-Verlag 🌐 English ⚖ 922 KB

Animal work has shown that carvedilol is a nonselective beta-blocking drug. It has a vasodilator action from alpha-receptor blockade, but there is evidence that it has further action to relax smooth muscle, possibly from calcium channel antagonism. Carvedilol is lipid soluble and 25% bioavailable, a

Clinical pharmacology of vinzolidine

✍ Willi Kreis; Daniel R Budman; Philip Schulman; Jean Freeman; Anne Greist; Robert 📂 Article 📅 1986 🏛 Springer 🌐 English ⚖ 424 KB

Clinical pharmacology — Training and car

Clinical pharmacology — Training and career

✍ X. Lataste; I. J. Whitehouse 📂 Article 📅 1981 🏛 Springer 🌐 English ⚖ 209 KB

Clinical pharmacology of mephenytoin and

Clinical pharmacology of mephenytoin and ethotoin

✍ Dr Allan S. Troupin; Patrick Friel; Mary Pat Lovely; Alan J. Wilensky 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 380 KB

Effective prescribing of anticonvulsants requires foreknowledge of baseline pharmacokinetic data. Little such information is available about the hydantoins other than phenytoin, although one of them, mephenytoin, is widely used. Useful pharmacokinetic data should be derived from patients already exp